Dopaminergic modulation of memory and affective processing in Parkinson depression

Lee X. Blonder; John T. Slevin; Richard J. Kryscio; Catherine A. Martin; Anders H. Andersen; Charles D. Smith; Frederick A. Schmitt

doi:10.1016/j.psychres.2013.06.003

Dopaminergic modulation of memory and affective processing in Parkinson depression

Lee X. Blonder, John T. Slevin, Richard J. Kryscio, Catherine A. Martin, Anders H. Andersen, Charles D. Smith, Frederick A. Schmitt

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Depression is common in Parkinson's disease and is associated with cognitive impairment. Dopaminergic medications are effective in treating the motor symptoms of Parkinson's disease; however, little is known regarding the effects of dopaminergic pharmacotherapy on cognitive function in depressed Parkinson patients. This study examines the neuropsychological effects of dopaminergic pharmacotherapy in Parkinsonian depression. We compared cognitive function in depressed and non-depressed Parkinson patients at two time-points: following overnight withdrawal and after the usual morning regimen of dopaminergic medications. A total of 28 non-demented, right-handed patients with mild to moderate idiopathic Parkinson's disease participated. Ten of these patients were depressed according to DSM IV criteria. Results revealed a statistically significant interaction between depression and medication status on three measures of verbal memory and a facial affect naming task. In all cases, depressed Parkinson's patients performed significantly more poorly while on dopaminergic medication than while off. The opposite pattern emerged for the non-depressed Parkinson's group. The administration of dopaminergic medication to depressed Parkinson patients may carry unintended risks.

Original language	English
Pages (from-to)	146-149
Number of pages	4
Journal	Psychiatry Research
Volume	210
Issue number	1
DOIs	https://doi.org/10.1016/j.psychres.2013.06.003
State	Published - Nov 30 2013

Bibliographical note

Funding Information:
The research reported in this publication was supported by the National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke grant R01MH78228 and by the Department of Veterans Affairs .

Funding

The research reported in this publication was supported by the National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke grant R01MH78228 and by the Department of Veterans Affairs .

Funders	Funder number
National Institute of Mental Health	R01MH078228
National Institute of Mental Health
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council
U.S. Department of Veterans Affairs

Keywords

Cognition
Dopamine
Emotion
Mood
Parkinson

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.psychres.2013.06.003

Cite this

@article{88fa01566e6641e19d3ef06f40edaf28,

title = "Dopaminergic modulation of memory and affective processing in Parkinson depression",

abstract = "Depression is common in Parkinson's disease and is associated with cognitive impairment. Dopaminergic medications are effective in treating the motor symptoms of Parkinson's disease; however, little is known regarding the effects of dopaminergic pharmacotherapy on cognitive function in depressed Parkinson patients. This study examines the neuropsychological effects of dopaminergic pharmacotherapy in Parkinsonian depression. We compared cognitive function in depressed and non-depressed Parkinson patients at two time-points: following overnight withdrawal and after the usual morning regimen of dopaminergic medications. A total of 28 non-demented, right-handed patients with mild to moderate idiopathic Parkinson's disease participated. Ten of these patients were depressed according to DSM IV criteria. Results revealed a statistically significant interaction between depression and medication status on three measures of verbal memory and a facial affect naming task. In all cases, depressed Parkinson's patients performed significantly more poorly while on dopaminergic medication than while off. The opposite pattern emerged for the non-depressed Parkinson's group. The administration of dopaminergic medication to depressed Parkinson patients may carry unintended risks.",

keywords = "Cognition, Dopamine, Emotion, Mood, Parkinson",

author = "Blonder, {Lee X.} and Slevin, {John T.} and Kryscio, {Richard J.} and Martin, {Catherine A.} and Andersen, {Anders H.} and Smith, {Charles D.} and Schmitt, {Frederick A.}",

note = "Funding Information: The research reported in this publication was supported by the National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke grant R01MH78228 and by the Department of Veterans Affairs . ",

year = "2013",

month = nov,

day = "30",

doi = "10.1016/j.psychres.2013.06.003",

language = "English",

volume = "210",

pages = "146--149",

number = "1",

}

TY - JOUR

T1 - Dopaminergic modulation of memory and affective processing in Parkinson depression

AU - Blonder, Lee X.

AU - Slevin, John T.

AU - Kryscio, Richard J.

AU - Martin, Catherine A.

AU - Andersen, Anders H.

AU - Smith, Charles D.

AU - Schmitt, Frederick A.

N1 - Funding Information: The research reported in this publication was supported by the National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke grant R01MH78228 and by the Department of Veterans Affairs .

PY - 2013/11/30

Y1 - 2013/11/30

N2 - Depression is common in Parkinson's disease and is associated with cognitive impairment. Dopaminergic medications are effective in treating the motor symptoms of Parkinson's disease; however, little is known regarding the effects of dopaminergic pharmacotherapy on cognitive function in depressed Parkinson patients. This study examines the neuropsychological effects of dopaminergic pharmacotherapy in Parkinsonian depression. We compared cognitive function in depressed and non-depressed Parkinson patients at two time-points: following overnight withdrawal and after the usual morning regimen of dopaminergic medications. A total of 28 non-demented, right-handed patients with mild to moderate idiopathic Parkinson's disease participated. Ten of these patients were depressed according to DSM IV criteria. Results revealed a statistically significant interaction between depression and medication status on three measures of verbal memory and a facial affect naming task. In all cases, depressed Parkinson's patients performed significantly more poorly while on dopaminergic medication than while off. The opposite pattern emerged for the non-depressed Parkinson's group. The administration of dopaminergic medication to depressed Parkinson patients may carry unintended risks.

AB - Depression is common in Parkinson's disease and is associated with cognitive impairment. Dopaminergic medications are effective in treating the motor symptoms of Parkinson's disease; however, little is known regarding the effects of dopaminergic pharmacotherapy on cognitive function in depressed Parkinson patients. This study examines the neuropsychological effects of dopaminergic pharmacotherapy in Parkinsonian depression. We compared cognitive function in depressed and non-depressed Parkinson patients at two time-points: following overnight withdrawal and after the usual morning regimen of dopaminergic medications. A total of 28 non-demented, right-handed patients with mild to moderate idiopathic Parkinson's disease participated. Ten of these patients were depressed according to DSM IV criteria. Results revealed a statistically significant interaction between depression and medication status on three measures of verbal memory and a facial affect naming task. In all cases, depressed Parkinson's patients performed significantly more poorly while on dopaminergic medication than while off. The opposite pattern emerged for the non-depressed Parkinson's group. The administration of dopaminergic medication to depressed Parkinson patients may carry unintended risks.

KW - Cognition

KW - Dopamine

KW - Emotion

KW - Mood

KW - Parkinson

UR - http://www.scopus.com/inward/record.url?scp=84885838641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885838641&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2013.06.003

DO - 10.1016/j.psychres.2013.06.003

M3 - Article

C2 - 23838419

AN - SCOPUS:84885838641

SN - 0165-1781

VL - 210

SP - 146

EP - 149

JO - Psychiatry Research

JF - Psychiatry Research

IS - 1

ER -

Dopaminergic modulation of memory and affective processing in Parkinson depression

Abstract

Bibliographical note

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this